Chronic pelvic pain. Pelvic and perineal pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 18-45 years Diagnosed by a gynecologist with chronic pelvic pain due to endometriosis Initial pain intensity based on a visual analog scale (VAS) greater than or equal to 4 Pain duration of at least 6 months Willingness to provide informed consent Consistent medication use for one month prior to trial start and failure to respond to drug therapy
Exclusion criteria
Exclusion criteria: History of other chronic pain conditions Neurological or psychiatric disorders Pregnant or lactating women Contraindications to tDCS use (e.g., metal implants in the head, active epilepsy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in pain intensity, measured by visual analog scale. Timepoint: At the beginning of the study (before treatment), at each of the 6 treatment sessions (to assess immediate changes in pain), 2 months, and 4 months after completion of treatment. Method of measurement: Questioning patients and recording scores on a visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Endometriosis Health Profile Scores-30. Timepoint: At the beginning of the study (to establish a baseline of the patients' quality of life status), 2 months after the end of treatment (to assess the effect of treatment on quality of life). Method of measurement: Endometriosis health profile -30 Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences